New Study Looks at Selumetinib for Treating Differentiated Thyroid Cancer
Nov 12, 2018
Interim results are in from a study evaluating whether adding selumetinib to RAI improves complete response, irrespective of MAPK pathway alterations.
Recent Content
The Link Between Diet Quality and CRC Outcomes
Nov 12, 2018
A study looks at how dietary patterns impact colorectal cancer outcomes before and after diagnosis.
Could Switching Opioids in Cancer Patients Provide Relief?
Nov 12, 2018
We spoke with Erin McMenamin, CRNP, of Penn Medicine, about the recent study on opioid switching in cancer patients.
Do Cash Incentives Improve CRC Screening Rates?
Nov 12, 2018
A study takes a closer look at colorectal cancer screening incentives among New York State Medicaid managed care patients.
New ASCO/SITC Guidance Addresses Shortcomings of Immuno-Oncology Trial Reporting
Nov 12, 2018
The recommendations on Trial Reporting in Immuno-Oncology aim to enchance understanding of efficacy and toxicity outcomes in immuno-oncology trials.
Can Exercise Offer Benefit in Advanced Lung Cancer Patients?
Nov 12, 2018
Many lung cancer patients may be unaware of the potential benefits of exercise.
Does Eating Organic Foods Decrease Cancer Risk?
Nov 9, 2018
We spoke with Kelly Hogan, MS, RD, about the recent JAMA study on the association between organic food consumption and cancer risk.
'Game-changing' New Treatment for NHS Lymphoma Patients
Nov 9, 2018
Cancer patients in England will receive a new game-changing therapy treatment under the first negotiated deal of its kind struck in Europe.
Inflammation Marker Prognostic in DLBCL
Nov 8, 2018
An inflammation marker was associated with several unfavorable characteristics in diffuse large B-cell lymphoma.
Study Sheds Light on Risk of Liver Injury in Combined Immunotherapy
Nov 8, 2018
The frequency of hepatotoxic immune-related adverse events varied in patients receiving one vs multiple chemotherapy agents.
